Mitral valve repair versus replacement in simultaneous aortic and mitral valve surgery
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F13%3A00058546" target="_blank" >RIV/00023001:_____/13:00058546 - isvavai.cz</a>
Výsledek na webu
<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716483/" target="_blank" >http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716483/</a>
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Mitral valve repair versus replacement in simultaneous aortic and mitral valve surgery
Popis výsledku v původním jazyce
BACKGROUND: Double valve replacement for concomitant aortic and mitral valve disease is associated with substantial morbidity and mortality. Excellent results with valve repair in isolated mitral valve lesions have been reported; therefore, whether its potential benefits would translate into better outcomes in patients with combined mitral-aortic disease was investigated. METHODS: A retrospective observational study was performed involving 341 patients who underwent aortic valve replacement with eithermitral valve repair (n=42) or double valve replacement (n=299). Data were analyzed for early mortality, late valve-related complications and survival. RESULTS: The early mortality rate was 11.9% for valve repair and 11.0% for replacement (P=0.797). Survival (+/- SD) was 67 +/- 11% in mitral valve repair with aortic valve replacement and 81 +/- 3% in double valve replacement at five years of follow-up (P=0.187). The percentage of patients who did not experience major adverse valve-related
Název v anglickém jazyce
Mitral valve repair versus replacement in simultaneous aortic and mitral valve surgery
Popis výsledku anglicky
BACKGROUND: Double valve replacement for concomitant aortic and mitral valve disease is associated with substantial morbidity and mortality. Excellent results with valve repair in isolated mitral valve lesions have been reported; therefore, whether its potential benefits would translate into better outcomes in patients with combined mitral-aortic disease was investigated. METHODS: A retrospective observational study was performed involving 341 patients who underwent aortic valve replacement with eithermitral valve repair (n=42) or double valve replacement (n=299). Data were analyzed for early mortality, late valve-related complications and survival. RESULTS: The early mortality rate was 11.9% for valve repair and 11.0% for replacement (P=0.797). Survival (+/- SD) was 67 +/- 11% in mitral valve repair with aortic valve replacement and 81 +/- 3% in double valve replacement at five years of follow-up (P=0.187). The percentage of patients who did not experience major adverse valve-related
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FA - Kardiovaskulární nemoci včetně kardiochirurgie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Ostatní
Rok uplatnění
2013
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Experimental and clinical cardiology
ISSN
1205-6626
e-ISSN
—
Svazek periodika
18
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
CA - Kanada
Počet stran výsledku
5
Strana od-do
22-26
Kód UT WoS článku
000319219000021
EID výsledku v databázi Scopus
—